TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100166,159.91+0.12%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 300.50+0.34%Gold$4,122.96−0.43%Brent$110.19+0.89%BTC$81,775.70−0.08%ETH$2,399.18−0.25%DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100166,159.91+0.12%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 300.50+0.34%Gold$4,122.96−0.43%Brent$110.19+0.89%BTC$81,775.70−0.08%ETH$2,399.18−0.25%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralClosed 🇸🇦Saudi ArabiaTadawul · TASIClosed 🇶🇦QatarQSE · QE GeneralClosed 🇺🇸United StatesNasdaq · NYSE · S&P 500Closed 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Open

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Grace Therapeutics Inc · Overview · TradingHolo

Markets › United States › NAS › GRCE

G

Grace Therapeutics Inc

NAS:GRCEHealthcarenasdaq_composite

$1.88−0.53%At closeAt close · Tue 20 Oct · ≈ AED 6.90 · Market cap $39.55M · Next earnings Thu 12 Nov

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

1D

−0.5%

1M

−10.9%

3M

−22.6%

6M

−59.0%

1Y

−40.7%

Why it's moving today

No company news in the last day; the move tracks its market and sector.

GRCE −0.53% today

✦ This week in three lines

No written digest yet for GRCE. The figures on this page are the source when one is written.

Financials

USD millions · annual5Y CAGR —

Valuation

P/E vs sector−5.1× vs −1.7×

Price / Book vs sector0.6× vs 2.0×

Price / Sales vs sector—

Price / Free cash flow vs sector−4.5× vs −1.5×

Forecasts

2 buy0 hold0 sell2 analysts

Average target$0.0000 −100.0%

Analysts0

EPS surprises, last 83 beats

Dividends

Yield0.0%

Annual payout—

Payout ratio0.0%

Next ex-date—

Years of growth—

Latest news

All GRCE news →

GLGrace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference

globenewswire · 47 d ago

GLGrace Therapeutics Announces First Quarter 2027 Financial Results, Provides Business Update

GlobeNewsWire · 68 d ago

GLGrace Therapeutics Announces $10 Million Private Placement

GlobeNewsWire · 76 d ago

Key facts

At close · Tue 20 Oct

Market cap (USD)$39.55M

P/E−5.1×

Dividend yield0.0%

52-week range$1.79 – $5.18

Avg volume (20d)106,474

Shares outstanding21,035,900

Beta0.37

Short interest10.1% of float

Next earningsThu 12 Nov

Radar Score

—

Value—

Quality—

Momentum—

Income—

Peer percentile within United States Healthcare0–100 · null when more than one input is missing

About

Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid…

Sector

Healthcare

IndustryNormal

ExchangeNAS

Peers

LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE

—−1.33%

JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE

—−0.69%

ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE

—−0.96%

UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE

—+1.36%